a large ongoing study of the epidemiology of drug-resistant TB in Peru, which is supported by grants from the U.S. National Institutes of Health. She is also the recipient of a Charles H. Hood Foundation Child Health Research Award and is supported by a career development award from the U.S. National Heart, Lung, and Blood Institute. For more than 15 years, Dr. Becerra has worked with Partners In Health—an international nonprofit organization that provides direct health care services and undertakes research and advocacy activities on behalf of those who are sick and living in poverty—helping to build and evaluate programs that treat patients with MDR TB.
Digambar Behera, M.D., is currently director of the LRS Institute of Tuberculosis and Respiratory Diseases in New Delhi. Formerly, he was professor in the Department of Pulmonary Medicine at the Postgraduate Institute of Medical Education and Research in Chandigarh. He completed his graduation from Sriram Chandra Bhanj Medical College in Cuttack in 1978 and post-graduation in medicine from the Postgraduate Institute of Medical Education and Research in Chandigarh in 1980. Dr. Behera has passed the National Board of Examinations in both General Medicine (1982) and Respiratory Medicine (1983). He received training at the University of Washington, Seattle, under the International Fogarty Fellowship awarded by NIH. Additionally, he received two International Cancer Research Exchange Technology Transfer Fellowships from the Union for International Cancer Control (UICC) to study lung cancer in Copenhagen, Denmark, and Sydney, Australia. Furthermore, he underwent training at the Memorial Sloan Kettering Cancer Center in New York. He has received 19 national and 7 international awards for his scientific contributions and has authored over 300 publications in national and international peer-reviewed journals. He is the author of six books, including one single-author two-volume textbook on pulmonary medicine, and is regarded as one of the foremost pulmonologists in India. Dr. Behera’s current research interests include the epidemiology, diagnosis, and management of drug-resistant TB, lung cancer, smoking, pollution, and induced changes in airway.
Gail H. Cassell, Ph.D., is a visiting professor in the Department of Social Medicine, Harvard Medical School, and Vice President of TB Drug Discovery for the not-for-profit Infectious Disease Research Institute in Seattle. Dr. Cassell recently retired as vice president, scientific affairs, and distinguished Lilly research scholar for infectious diseases, Eli Lilly & Co., in Indianapolis, Indiana. In this capacity, among other things, she was responsible for initiating and leading the not-for-profit Lilly TB Drug Discovery Initiative, launched in 2007. In 2003, she was one of two individuals at Lilly who initiated and developed the Lilly Multidrug Resistant Tuberculosis Partnership.